Miha Stajdohar is the CTO and co-founder of Genialis, redefining precision oncology with AI and RNA. Passionate about advancing healthcare and improving outcomes for patients, their families, and communities, Miha led the development of an FDA-accepted AI-based biomarker, helping bring the promise of precision medicine into clinical practice. He holds a PhD in computer science from the University of Ljubljana, with a focus on data integration and AI, and completed postdoctoral research at Baylor College of Medicine. With nearly two decades of experience in AI and biomedical research, he has published in the fields of artificial intelligence, network analysis, and bioinformatics. In his free time, Miha finds inspiration in mountain adventures and sailing the Adriatic.
Coming soon.
"*" indicates required fields
